CCL2 and familial pancreatic carcinoma: MCP-1 is also known to enhance cancer migration, invasion, and metastasis [27, 83–85], and its expression in solid tumors, including pancreatic cancer, serves as a poor prognostic biomarker associated with shorter patient survival.